Press "Enter" to skip to content

Johns Hopkins #1 for Psych; Pediatric ADHD Tx Hits Shelves; Fish Oil for BPD

Johns Hopkins Hospital in Baltimore took U.S. News & World Report‘s top spot in their list of best psychiatry hospitals, followed by McLean Hospital in Belmont, Massachusetts, and Massachusetts General Hospital in Boston, who took the number two and three spots, respectively.

West Virginia could stand to recoup up to $26 billion in a settlement with opioid maker Johnson & Johnson and drug distribution firms AmerisourceBergen, Cardinal Health, and McKesson. (ABC News)

The pediatric ADHD treatment Azstarys (serdexmethylphenidate and dexmethylphenidate) — FDA approved in March — is now available in the U.S., Corium announced.

The number of schizophrenia diagnoses has increased nearly fourfold in Denmark over the past 20 years, possibly driven by an uptake in cannabis use disorder. (JAMA Psychiatry)

Charlie Riordan, MD, of Yale University’s department of psychiatry, best known for his work in addiction psychiatry, passed away at the age of 83. (Yale School of Medicine)

Adding marine omega-3 fatty acids like fish oil supplements as adjunct therapy helped improve some symptoms of borderline personality disorder, including behavioral dyscontrol and affective dysregulation. (Journal of Clinical Psychiatry)

MindX Sciences announced that it is the recipient of a second patent for a novel suicidality risk assessor.

In related news, a new study found that U.S. Muslim adults were twice as likely to have a history of a suicide attempt versus adults of other religions or atheists. (JAMA Psychiatry)

  • Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and dermatology news. Based out of the New York City office, she’s worked at the company for nearly five years.

Source: MedicalNewsToday.com